A pilot study on mindfulness based stress reduction for smokers by Davis, James M et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Complementary and 
Alternative Medicine
Open Access Research article
A pilot study on mindfulness based stress reduction for smokers
James M Davis*1, Michael F Fleming2, Katherine A Bonus3 and 
Timothy B Baker1
Address: 1Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, 1930 Monroe St., Suite 
200, Madison WI 53711-2027, USA, 2Department of Family Medicine, University of Wisconsin School of Medicine and Public Health, 777 South 
Mills St., Madison WI 53715, USA and 3Health Mindfulness Program, University of Wisconsin School of Medicine and Public Health, 621 Science 
Dr., Madison, WI53711, USA
Email: James M Davis* - jd4@medicine.wisc.edu; Michael F Fleming - mfleming@fammed.wisc.edu; 
Katherine A Bonus - kbonus@uwhealth.org; Timothy B Baker - tbb@ctri.medicine.wisc.edu
* Corresponding author    
Abstract
Background:  Mindfulness means paying attention in the present moment, non-judgmentally,
without commentary or decision-making. We report results of a pilot study designed to test the
feasibility of using Mindfulness Based Stress Reduction (MBSR) (with minor modifications) as a
smoking intervention.
Methods: MBSR instructors provided instructions in mindfulness in eight weekly group sessions.
Subjects attempted smoking cessation during week seven without pharmacotherapy. Smoking
abstinence was tested six weeks after the smoking quit day with carbon monoxide breath test and
7-day smoking calendars. Questionnaires were administered to evaluate changes in stress and
affective distress.
Results: 18 subjects enrolled in the intervention with an average smoking history of 19.9 cigarettes
per day for 26.4 years. At the 6-week post-quit visit, 10 of 18 subjects (56%) achieved biologically
confirmed 7-day point-prevalent smoking abstinence. Compliance with meditation was positively
associated with smoking abstinence and decreases in stress and affective distress.
Discussions and conclusion: The results of this study suggest that mindfulness training may
show promise for smoking cessation and warrants additional study in a larger comparative trial.
1. Background
Mindfulness may be characterized as paying attention to
the moment-to-moment unfolding of internal experience
such as physical sensation, emotion, craving, agitation,
etc; while maintaining a mental posture of acceptance
toward each experience as a passing phenomenon with-
out acting on it, judging it, ruminating about it, or trying
to fix it [1-3]. Mindfulness is a skill, and like learning a
musical instrument, is developed through repeated daily
practice. An intended result of mindfulness practice is that
a mental orientation of mindfulness will develop toward
daily events providing enhanced mental/emotional flexi-
bility and clarity to deepening one's enjoyment of life and
making one more skillful in facing life's challenges.
The secular instruction of mindfulness has been formu-
lated through Mindfulness Based Stress Reduction
(MBSR), a stress reduction program developed by Jon
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Kabat-Zinn, now taught in over 240 institutions world-
wide [4]. MBSR is structured to provide basic instructions
in mindfulness and in starting a daily meditation practice
to individuals, most of whom have not had prior exposure
to the subject. MBSR requires participants to meet as a
group for 2–3 hours, once per week, for eight weeks, meet
for a 7-hour "day of mindfulness", and practice mindful-
ness meditation 45 minutes per day, six days per week.
One motivation for developing a study to evaluate the
effect of mindfulness training on smoking cessation is that
mindfulness training has been shown to decreases stress,
a trigger for tobacco use. Stress has been strongly corre-
lated with smoking rate and relapse rate through studies
evaluating financial stress [4], social stress [5], and stress
of job loss [5]. Studies on mindfulness training have dem-
onstrated a reduction in stress related symptoms [6], and
reductions in salivary cortisol (a biomarker for stress)
[12,21].
Another motivation for evaluating the effect of mindful-
ness on smoking cessation is that mindfulness training
has been shown to decreases negative affect, also associ-
ated with drug use behavior. Mounting studies support
the idea that negative affect is a potent stimulus for drug-
seeking behavior and smoking relapse [7-10]. Several
studies have shown mindfulness training to be associated
with a reduction in affective distress of mood disturbances
[11-14]. Other studies have shown an association
between mindfulness training and improved sense of
well-being [15-17] as well as mindfulness and decreased
depressive relapse [18-20].
A mechanism postulated for the use of mindfulness in
smokers is that mindfulness might be used as a cognitive
skill for managing craving, withdrawal symptoms and
emotional distress, and that this skill might persist
through time exerting a long-term effect on response to
smoking cues. The pilot study had a more preliminary
scope of inquiry, to test feasibility and determine if addi-
tional study is warranted.
2. Methods
2.1. Recruitment
Subjects were recruited from the Dane County, Wiscon-
sin, region, using a pre-existing smoking study recruit-
ment phone list managed through the University of
Wisconsin School of Medicine and Public Health, Center
for Tobacco Cessation and Intervention (UW-CTRI).
Advertising used the statement "Quit Smoking Study"
without reference to meditation. Subjects from this phone
list had been excluded from a previous study because they
a) reported that they would not remain in the region for 3
years (n = 10), b) reported a recent history of anxiety,
depression or bipolar disorder (n = 5), or c) reported past,
but not current use of Bupropion (n = 4). Inclusion crite-
ria required subjects to be 18 or over and smoke 10 or
more cigarettes per day. No exclusion criteria were used,
though incidentally no subjects used NRT or Bupropion
during the study. Twenty-two potential subjects attended
a one-hour orientation describing the intensive nature
and time requirements of the intervention. Of these, 18
subjects signed the consent form and attended the first
class. The other four excluded themselves after the orien-
tation, reporting "scheduling" or "transportation" con-
straints. The study protocol received approval from, and
followed procedures in accord with, the standards of the
University of Wisconsin Health Sciences Institutional
Review Board.
2.2. Intervention
MBSR was taught to participants in the usual manner by
instructors at the UW Health Mindfulness Program with-
out alteration of the central course content or require-
ments. As a smoking intervention, there were some
differences from a typical MBSR course: subjects entered
the intervention with the express purpose of smoking ces-
sation; a quit date was provided, addiction questionnaires
and carbon monoxide testing was performed at each
weekly meeting, and course instructions were focused at
times on how one might apply mindfulness to craving
and withdrawal symptoms. In the spirit of non-goal-
directedness central to mindfulness training, subjects were
encouraged not to focus on smoking cessation as a "goal"
for the intervention, but instead, to direct their intention
toward developing a mindful orientation toward their
lives. Subjects were encouraged to apply moment-to-
moment non-judgmental awareness to strong emotions
or thoughts, which in this case often involved craving,
negative affect, or withdrawal symptoms. Subjects were
encouraged to practice mindfulness throughout their day,
including during meals, social interactions, and moments
associated with situational drug use threats. The quit-
smoking day was on the 7-hour "day of mindfulness", ten
days prior to the end of the intervention. Considerable
testing was performed at the final meeting. No pharmaco-
therapy was used.
2.3. Outcome measures
Measures of meditation compliance, smoking, and stress
were taken at each meeting, including one day, eight days
and six weeks post quit. Compliance with meditation was
tested via 7-day meditation calendars provided weekly.
Smoking abstinence was tested via 7-day smoking calen-
dars and verified via carbon monoxide breath test (absti-
nence defined as a carbon monoxide level under10 ppm)
[22,23]. Questionnaires used to test changes in reported
stress and affective distress included respectively, the Per-
ceived Stress Scale (PSS) and the Symptoms Check List
(SCL-90-R). The Perceived Stress Scale is a questionnaireBMC Complementary and Alternative Medicine 2007, 7:2 http://www.biomedcentral.com/1472-6882/7/2
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designed to provide an assessment of symptoms of stress
over the previous week. The PSS has robust reliability and
validity [34] and has been used in multiple studies to
measure the effect of mindfulness training on stress [18-
21]. SCL-90-R is a 90 item questionnaire designed to test
self-reported affective distress associated with nine catego-
ries: Somatization, Obsessive Compulsive Disorder, Inter-
personal Sensitivity, Depression, Anxiety, Hostility,
Phobic Anxiety, Paranoid Ideation and Psychoticism. The
SCL-90-R has been used in numerous studies on mindful-
ness [11,13,19], and reliability and validity has been
tested in multiple populations [24-31].
.
3. Results
3.1. Sample characteristics
The sample (n = 18) had an average age of 45.2 years
(range: 22 – 67), was composed of 10 women and 8 men,
all Caucasian. The average cigarettes smoked per day was
19.9 (range: 10 – 40), and average number of years
smoked was 26.4 (range: 4 – 44). Subjects were not
excluded based on motivation to quit smoking, however,
during recruitment all potential subjects in the study
reported their motivation to quit smoking as "high". Sub-
jects reported no use of tobacco related pharmacotherapy.
3.2. Compliance with daily meditation
Subjects were provided with an audio-CD with a 45
minute guided meditation, asked to use the CD once a
day, six days a week (270 minutes per week) and perform
additional meditation if possible. Subjects were asked to
record the number of minutes of meditation practiced
each day in a logbook and were strongly encouraged to be
consistent and honest in their daily reporting. Of the 18
subjects that completed the study, 3 patterns of compli-
ance were evident: 1) those meditating equal to or more
than the requested minimum (270 minutes per week)
were defined as "highly compliant meditators"; 2) those
who meditated less than the requested minimum were
defined as "moderately compliant meditators"; and 3)
those who stopped meditating within the first 4 weeks of
the intervention were defined as "non-compliant medita-
tors". Highly compliant meditators (n = 8) meditated a
mean of 51.8 min/day (SD = 12.6 min/day); moderately
compliant meditators (n = 5) meditated mean of 23.4
min/day (SD = 6.1 min/day), and non-compliant medita-
tors (n = 5) meditated mean of 11.3 min/day (SD = 5.2
min/day). Differences in meditation time between groups
were primarily the effect of missed days of meditation,
though meditations under 45 minutes played a small role
as well.
3.3. Attrition
All highly and moderately compliant meditators
remained in the intervention. All non-compliant medita-
tors (n = 5) dropped out of the intervention before the
quit date. Three of the five non-compliant meditators
dropped out during the 2nd week, the other two dropped
out during the 4th week. Follow-up phone calls revealed
the following reasons for dropout: "conflicts with summer
vacation scheduling"(n = 3); "not enough time for daily
meditation" (n = 1); and "meditation is too hard" (n = 1).
Because these subjects dropped out, post-quit data was
not available from carbon monoxide testing, smoking
logbooks, and written instruments. Phone interviews at
the 6-week post-quit follow-up revealed that none who
dropped out stopped smoking on their own.
3.4. Smoking abstinence at the 6-week follow-up visit
Smoking abstinence was tested via weekly 7-day smoking
calendars and confirmed via weekly carbon monoxide
(CO) breath tests. There were no discrepancies between
self-reported abstinence and CO-level defined abstinence.
Of the 18 subjects who entered the intervention, ten
(55.6%) (95% CI = 32.7–78.5) attained point-prevalent
abstinence six weeks after the quit date. Of the eight sub-
jects who failed to attain abstinence, five failed due to
dropout before the quit date, while three quit but relapsed
before the 6-week follow up.
3.5. Predictors of smoking abstinence
Post-hoc analysis was performed to identify differences
between subjects who did and did not achieve biologi-
cally confirmed 6-week point prevalent smoking absti-
nence. Factors that predicted abstinence were time in
meditation, interest in meditation and affective distress.
Abstinent subjects (n = 10) meditated a mean 45.3 (SD =
15.8) minutes per day vs. non-abstinent subjects (n = 3)
(excluding dropouts) who meditated a mean of 22.4 (SD
= 5.2) minutes per day. The difference for time in medita-
tion between groups was significant by two-sample t-test
(t(11) = 2.4, p = .03). Inclusion of dropouts in this calcula-
tion increased the magnitude and significance of the dif-
ference between groups. Reporting a "strong interest" in
meditation significantly predicted smoking abstinence by
two-proportion z test (abstinent 80% vs. non-abstinent
25%; z = 2.33, p < .01). Finally, greater baseline affective
distress predicted smoking abstinence (pooled two-sam-
ple t-test: t(10) = 2.4, p = .04). Abstinent subjects had a
mean baseline SCL-90-R score of 89.9 (SD = 30.1; one
incomplete test result was omitted) while non-abstinent
subjects had a mean score of 57.8 (SD = 30.4).
3.6. Symptoms of stress in moderately vs. highly compliant 
meditators
Moderately vs. highly compliant meditators were com-
pared with regard to symptoms of stress (PSS) at baselineBMC Complementary and Alternative Medicine 2007, 7:2 http://www.biomedcentral.com/1472-6882/7/2
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and at 1-day post-quit (highest post-quit PSS scores for all
groups). Moderately compliant meditators showed an
increase of mean PSS scores from 19 (baseline) to 24 (1-
day post-quit) compared to highly compliant meditators
who showed a decrease in mean PSS scores from 20.25
(baseline) to 17.25 (1-day post-quit) (Figure-1). The dif-
ference in change of PSS scores between the two groups
was significant with t-test for equal variance: t(11) = -3.11,
(p < .01) (Levenes's test showed similar variance). As with
most pilot studies, outliers with a small sample size may
have contributed to the significance.
3.7. symptoms of affective distress in moderately vs. highly 
compliant meditators
Symptoms of affective distress (SCL-90-R) were assessed
at two time points only: baseline and the 8-day post-quit
visit. Moderately compliant meditators showed a decrease
in mean SCL-90-R scores from 93.8 (baseline) to 90.8
(10-days post-quit) compared to highly compliant medi-
tators who decreased from 72.6 (baseline) to 43.9 (10-
days post-quit) (Figure-2). The difference in change of
mean SCL-90-R scores between the two groups was 25.7
points but not significant with t-test for equal variance:
t(11) = -1.38, (p < .19) (Levenes's test showed similar vari-
ance).
3.8. Subject acceptance
During the final meeting (10-days post-quit) subjects
completed a course evaluation. This provided an opportu-
nity for subjects to make recommendations for future
devolvement of the intervention. The course evaluation
contained open-ended questions as well as directed ques-
tions regarding perceived strengths and weaknesses of the
intervention. Representative responses to the open-ended
question, "What did you like or dislike about the course?"
included:
￿ "I never thought that I would enjoy meditation but I
found that I do it every day. Quitting smoking is only one
of many benefits of mindfulness."
￿ "Everyone was wonderful. I feel empowered for the first
time in years. I've decided to get a better job."
￿ "I am sleeping better and I have more energy."
Responses to directed questions provided more critical
feedback and included the following:
￿ "Was there was enough time spent on exercises for
smoking cessation?" Four said "no".
￿ "Did the course end too soon after quit date?" Ten said
"yes".
￿ "Did you need more help with withdrawal symptoms?"
Six said "yes".
4. Discussions and conclusion
4.1. Abstinence
A 6-week abstinence rate of 56% is relatively high when
compared to results of a previous comparable study pop-
ulation showing 33% point prevalent 6-week post-quit
abstinence rate in a when provided with moderately
intensive counseling, no pharmacotherapy, and seen
weekly at the time of testing [33]. It is noteworthy that ten
of the thirteen subjects who attempted to quit (did not
drop out) achieved abstinence at six weeks. The best
explanation for this may be that MBSR is an intensive
intervention and that due to its intensive nature, dropout
rates are high but success rates in those who complete the
intervention is also high. Although there were considera-
ble limitations to this pilot study, this relatively high
abstinence rate suggests that mindfulness training may
have some promise as an intervention for smoking cessa-
tion.
4.2. Meditation compliance as a possible predictor of 
smoking abstinence
In this sample, compliance with meditation practice
appeared to be associated with smoking abstinence. The
point-prevalent 6-week abstinence rate was 100% among
highly compliant meditators, 40% among moderately
compliant meditators and 0% among non-compliant
meditators (dropouts). One conclusion from this data
would be that compliance with meditation is a trait of
smokers who are motivated to quit and that meditation
itself does not confer a therapeutic effect. Results from
baseline questionnaires on motivation to quit smoking,
however, do not support this: all subjects reported a
"high-level of motivation" to quit smoking. Even if medi-
tation time did co-vary with motivation to quit, the asso-
ciation between meditation time and smoking abstinence
makes it difficult to dismiss the possibility that medita-
tion provided some effect over and above motivation
alone.
4.3. Interest in learning meditation may predict smoking 
abstinence
Subjects with a baseline report of a "strong interest in
learning meditation" had a significantly higher 6-week
point prevalent abstinence. The further finding that eight
of the ten who achieved abstinence also reported a strong
interest in meditation at baseline, suggests that interest in
meditation and compliance with meditation may be
related. The findings suggest that the intervention may be
most effect for smokers with an interest in learning medi-
tation.BMC Complementary and Alternative Medicine 2007, 7:2 http://www.biomedcentral.com/1472-6882/7/2
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Perceived Stress after Quitting Smoking in Moderately vs. Highly Compliant Meditators Figure 1
Perceived Stress after Quitting Smoking in Moderately vs. Highly Compliant Meditators.
Changes in Stress in Moderately vs. Highly  Compliant Meditators
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Changes in Affective Distress in Moderately vs. Highly Compliant Meditators.
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4.4 Affective distress may predict smoking abstinence
Subjects with higher SCL-90-R scores appeared to achieve
higher levels of 6-week point prevalent abstinence. It
appears to be counter-intuitive that subjects with higher
levels of affective distress would achieve higher levels of
abstinence. If however, we consider the possibility that
the intervention may provide relief from affective distress,
subjects with higher affective distress may achieve more
benefits from mindfulness, and so are more motivated to
practice.
4.5. Changes in reported stress and affective distress
The finding that highly compliant meditators demon-
strated substantial decreases in reported stress and affec-
tive distress and attained 100% abstinence suggests the
possibility that reduction in stress or affective distress may
be a therapeutic mechanism by which mindfulness train-
ing has its potential effect. A decrease in stress in highly
compliant meditators after quitting smoking is not a typ-
ical finding for smoking cessation interventions and sug-
gests that meditation may exert an effect on outcomes
though stress reduction. Another finding in the study was
that highly compliant compared to non-compliant medi-
tators demonstrated a drop in SCL-90-R scores. The differ-
ence, however, was confounded in this small sample by a
large variance and did not reach statistical significance. As
such, it is unclear from these study results whether com-
pliance with meditation in this sample is associated with
decreased affective distress.
4.6. Study limitations
A principal limitation to the intervention's effectiveness is
the omission of pharmacotherapy. Pharmacotherapy was
purposefully excluded from the study so as to allow for
the appraisal of mindfulness training as a smoking inter-
vention without the confounding therapeutic effects of
medication. Limitations of the study also include a small
sample size, absence of a control group and short-term
follow-up. Since this was a pilot study aimed at assessing
feasibility, pre-post study design was used and compari-
sons were made post-hoc based on compliance with med-
itation practice. Additionally, the program orientation,
which discouraged four individuals from participating,
may have introduced a selection bias that would lead to
an overestimation of the intervention efficacy in other
populations. Subsequent testing of mindfulness training
as a smoking intervention would include the use of phar-
macotherapy, random assignment of smokers to the inter-
vention vs. control group, and six-month follow-up.
4.7. Attrition
Attrition rate was five of eighteen subjects (28%) with
three dropouts in the first two weeks. Exit interviews with
dropouts suggest that subjects left the study primarily
because they were unaware of the high time commitment
or unaware of the nature of the intervention (meditation
practice). Thus, it is possible that the attrition rate would
decrease if the nature and intensity of the intervention
were made clearer to prospective subjects.
4.8. Compliance with meditation practice
There appeared to be a high level of compliance with
meditation among those in the study. Even those later cat-
egorized as "moderately compliant meditators" meditated
on average 23.4 minutes per day. Notably, recruitment
flyers advertised only a "quit smoking study" with no
mention of meditation and no subjects were excluded
based on motivation. It could be that our small sample
was uncharacteristically motivated to learn meditation or
may be due to the fact that highly skilled veteran mindful-
ness instructors who are skilled at motivating mindfulness
practice.
4.9. Further study
A majority of the sample recruited expressed a "strong
interest" in meditation, a characteristic most likely not
reflected in the population at large. The intensive training
program might be cost-effective for treatment-resistant
smokers who are unable to quit with less intensive inter-
ventions. Given the rather high abstinence rates in this
small sample, and relative increased effectiveness in sub-
jects with higher levels of affective distress, mindfulness
training may hold promise in select and challenging pop-
ulations. From the results available, a larger randomized
comparative trial appears to be warranted.
Abbreviations
Mindfulness Based Stress Reduction (MBSR)
University of Wisconsin School of Medicine and Public
Health, Center for Tobacco
Cessation and Intervention (UW-CTRI).
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
JM Davis designed the study, recruited subjects, per-
formed data collection, analysis and manuscript writing.
MF Fleming and TB Baker provided oversight in study
design, interpretations of results and manuscript writing.
KA Bonus was a full collaborator in the intervention
design and directed intervention implementation. All
authors read and approved the final manuscript.
Acknowledgements
• Diana Grove, R.N., and Laura Pinger, M.S., UW Health Mindfulness Pro-
gram; full collaborators in the development and implementation of the 
interventionBMC Complementary and Alternative Medicine 2007, 7:2 http://www.biomedcentral.com/1472-6882/7/2
Page 7 of 7
(page number not for citation purposes)
• Stevens Smith, PhD., UW Medical School Center for Tobacco Research 
and Intervention; statistical consultant for data analysis and interpretation
• Richard Davidson Ph. D., Donal G. MacCoon, Ph. D., UW Department of 
Psychology; consultants to help ensure a rigorous academic approach to 
the study of mindfulness
• UW Medical School Center for Tobacco Research and Intervention
• UW Health Mindfulness Program
• UW Department of Family Medicine
• This study was supported by grant number T32 AA14548 from the 
National Institute of Alcohol Abuse and Alcoholism (NIAAA), Rockville, 
MD.
References
1. Goldstein J, Kornfield J: Seeking the heart of wisdom Boston, MA: Sham-
bhala Publications; 1987. 
2. Kabat-Zinn J: Full catastrophe living New York: Dell Publishing; 1990. 
3. Segal ZV, Williams JMG, Teasdale JD: Mindfulness based cognitive
behavioral therapy New York: Guilford Press; 2002. 
4. Siahpush M, Carlin JB: Financial stress, smoking cessation and
relapse: results from a prospective study of an Australian
national sample.  Addiction 2006, 101:121-127.
5. Niaura R, Shadel WG, Britt DM, Abrams DB: Response to social
stress, urge to smoke, and smoking cessation.  Addict Behav
2002, 27:241-250.
6. Speca M, Carlson LE, Goodey E, Angen M: A randomized, wait-list
controlled clinical trial: the effect of a mindfulness medita-
tion-based stress reduction program on mood and symp-
t o m s  o f  s t r e s s  i n  c a n c e r  o u t p a t i e n t s .   Psychosom Med 2000,
62:613-622.
7. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC: Addic-
tion motivation reformulated: An affective processing
model of negative reinforcement.  Psychological Review 2004,
111:33-51.
8. Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB:
Predicting relapse back to smoking: Contrasting affective
and physical models of dependence.  Journal of Consulting and Clin-
ical Psychology 2002, 70:216-227.
9. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB: Smoking
withdrawal dynamics: I. Abstinence distress in lapsers and
abstainers.  Journal of Abnormal Psycholog 2003, 112:3-13.
10. Fiore MC, Bailey WC, Cohen SJ: Rockville, MD: U.S. Department of
Health and Human Services, U.S. Public Health Service; 2000. 
11. Brown KW, Ryan RM: The benefits of being present: mindful-
ness and its role in psychological well-being.  J Pers Soc Psychol
2003, 84:822-848.
12. Carlson LE, Speca M, Patel KD, Goodey E: Mindfulness-based
stress reduction in relation to quality of life, mood, symp-
toms of stress and levels of cortisol, dehydroepiandroster-
one sulfate (DHEAS) and melatonin in breast and prostate
cancer outpatients.  Psychoneuroendocrinology 2004, 29:448-474.
13. Kabat-Zinn J, Massion AO, Kristeller J, Peterson LG, Fletcher KE,
Pbert L, Lenderking WR, Santorelli SF: Effectiveness of a medita-
tion-based stress reduction program in the treatment of
anxiety disorders.  Am J Psychiatry 1992, 149:936-943.
14. Weiss M, Nordlie JW, Siegel EP: Mindfulness-based stress reduc-
tion as an adjunct to outpatient psychotherapy.  Psychother Psy-
chosom 2005, 74:108-112.
15. Beddoe AE, Murphy SO: Does mindfulness decrease stress and
foster empathy among nursing students?  J Nurs Educ 2004,
43:305-312.
16. Rosenzweig S, Reibel DK, Greeson JM, Brainard GC, Hojat M: Mind-
fulness-based stress reduction lowers psychological distress
in medical students.  Teach Learn Me 2003, 15:88-92.
17. Shapiro SL, Schwartz GE, Bonner G: Effects of mindfulness-based
stress reduction on medical and premedical students.  J Behav
Med 1998, 21(6):581-599.
18. Ma SH, Teasdale JD: Mindfulness-based cognitive therapy for
depression: replication and exploration of differential
relapse prevention effects.  J Consult Clin Psychol 2004, 72:31-40.
19. Teasdale JD, Moore RG, Hayhurst H, Pope M, Williams S, Segal ZV:
Metacognitive awareness and prevention of relapse in
depression: empirical evidence.  J Consult Clin Psychol 2002,
70:275-287.
20. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau
MA: Prevention of relapse/recurrence in major depression by
mindfulness-based cognitive therapy.  J Consult Clin Psycho 2000,
68:615-623.
21. Marcus BH, Lewis BA, King TK, Albrecht AE, Hogan J, Bock B, Parisi
AF, Abrams DB: Rationale, design, and baseline data for Com-
mit to Quit II: An evaluation of the efficacy of moderate-
intensity physical activity as an aid to smoking cessation in
women.  Preventive Medicine 2003, 36:479-492.
22. Cummings SR, Richard RJ: Optimum cutoff points for biochem-
ical validation of smoking status.  Am J Public Health 1988,
78:574-575.
23. Pearce MS, Hayes L: Self-reported smoking status and exhaled
carbon monoxide: results from two population-based epide-
miologic studies in the North of England.  Chest 2005,
128:1233-1238.
24. Derogatis LR, Rickels K, Rock AF: The SCL-90-R and the MMPI:
a step in the validation of a new self-report scale.  Br J Psychiatry
1976, 128:280-289.
25. Aben I, Verhey F, Lousberg R, Lodder J, Honig A: Validity of the
beck depression inventory, hospital anxiety and depression
scale, SCL-90-R, and Hamilton depression rating scale as
screening instruments for depression in stroke patients.  Psy-
chosomatics 2002, 43:386-393.
26. Barker-Collo SL: Culture and validity of the Symptom Check-
list-90-Revised and Profile of Mood States in a New Zealand
student sample.  Cultur Divers Ethnic Minor Psycho 2003, 9:185-196.
27. Brophy CJ, Norvell NK, Kiluk D: An examination of the factor
structure and convergent and discriminant validity of the
SCL-90-RR in an outpatient clinic population.  J Pers Assess
1988, 52:334-340.
28. Kim SW, Dysken MW, Kuskowski M: The Symptom Checklist-
90: Obsessive-Compulsive Subscale: A reliability and validity
study.  Psychiatry Res 1992, 41(1):37-44.
29. Kinney RK, Gatchel RJ, Mayer TG: The SCL-90-RR evaluated as
an alternative to the MMPI for psychological screening of
chronic low-back pain patients.  Spine 1991, 16:940-942.
30. Morgan CD, Wiederman MW, Magnus RD: Discriminant validity
of the SCL-90-R dimensions of anxiety and depression.
Assessment 1998, 5:197-201.
31. Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W:
The Symptom Check-List-90-R (SCL-90-R-R): a German val-
idation study.  Qual Life Re 2000, 9:185-193.
32. Canter PH, Ernst E: The cumulative effects of Transcendental
Meditation on cognitive function – a systematic review of
randomised controlled trials.  Wien Klin Wochenschr 2003,
115:758-766.
33. Jorenby DE, Leishow SJ, Mides MA, Rennard SI, Johnston JA, Hughes
AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC,
Baker TB: A Controlled Trial of Sustatined – Release Bupro-
pion, a Nicotine Patch or Both for Smoking Cessation.  New
England Journal of Medicine 1999, 9:685-691.
34. Cohen S, Kamarck T, Mermelstein R: A global measure of per-
ceived stress.  J Health Soc Behavior 1983, 24:385-396.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6882/7/2/prepub